GlassScriptPhysician profile
Mark J Rogovin
NPI 1891721999
$4,830.22
in general payments reported to CMS, 2019-2025
39 companies · $556 in 2025
The $556 reported for 2025 was more than what 75% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $989 · 2020: $240 · 2021: $1,139 · 2022: $880 · 2023: $524 · 2024: $503 · 2025: $556.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,582.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,581.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $518.97 | 2019-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Novo Nordisk INC | $436.17 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $418.00 | 2019-2025 | |
| Lilly USA, LLC | $394.48 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Abbvie INC. | $374.43 | 2021-2023 | Ubrelvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $289.91 | 2019-2025 | Jardiance |
| Amgen INC. | $270.42 | 2019-2025 | Otezla, Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $246.01 | 2019-2025 | Airsupra |
| Novartis Pharmaceuticals Corporation | $245.76 | 2019-2023 | |
| Amarin Pharma, INC. | $175.74 | 2019-2022 | |
| Exact Sciences Corporation | $165.41 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Janssen Pharmaceuticals, INC | $160.04 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $155.85 | 2021-2024 | |
| Avanir Pharmaceuticals, INC. | $126.21 | 2019 | |
| Merck Sharp & Dohme LLC | $121.02 | 2019-2024 | Capvaxive, Gardasil, Gardasil 9 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Rogovin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.